ESR1 and myocardial infarction: Long-term raloxifene treatment does not activate ERα, but activates GPER instead [70,99], reducing MI-induced arrhythmias and attenuating cardiac damage and apoptosis after I/R in OVX rats, which correlates to lower neutrophil infiltration and suppression of NF-κB activity [100].